| 2025-05-29 10:04:00 |
Collaborations For Change: Aua And Pfizer Select Recipients For $1.5 Million Grant Program To Improve Advanced Prostate Cancer Care
Baltimore, may 29, 2025 (globe newswire) -- the american urological association (aua) is excited to announce it has selected seven grant winners to split $1.5 million as part of a collaborative initiative with pfizer external research & grants (er&g) which is aimed to improve the quality of care for individuals with advanced prostate cancer. |
| 2025-05-22 17:00:00 |
Astellas And Pfizer’s Xtandi™ (enzalutamide) Shows Long-term Overall Survival In Metastatic Hormone-sensitive Prostate Cancer
Five-year follow-up data from the phase 3 arches trial shows xtandi (enzalutamide) plus androgen deprivation therapy (adt) reduces risk of death by 30% after a median follow-up of 61.4 months, treatment with xtandi (enzalutamide) plus adt was associated with a 66% probability of survival at five years compared to 53% probability of survival with placebo plus adt xtandi (enzalutamide) is the first and only androgen receptor inhibitor to demonstrate an overall survival benefit at five years in men with metastatic hormone-sensitive prostate cancer data continue to show wide-ranging effect of treatment with xtandi (enzalutamide) plus adt across various patient subgroups, notably those with high-volume disease, no prior docetaxel use, and synchronous disease long-term data reinforce xtandi (enzalutamide) plus adt as a standard of care tokyo and new york , may 22, 2025 /prnewswire/ -- astellas pharma inc. (tse: 4503, president and ceo: naoki okamura, ’astellas’) and pfizer inc. (nyse: pfe) today announced longer-term follow-up results from an open-label extension of the phase 3 arches (nct02677896) study, reporting a five-year follow up of overall survival (os) benefits and a 30% reduction in the risk of death in men with metastatic hormone-sensitive prostate cancer (mhspc) treated with xtandi™ (enzalutamide), an androgen receptor pathway inhibitor (arpi), plus androgen deprivation therapy (adt) compared to placebo plus adt. these data will be presented during an oral presentation (abstract #5005) at the american society of clinical oncology (asco) annual meeting in chicago (tuesday, june 3, 9:45 a.m. |
| 2025-05-21 08:00:00 |
Sk Bioscience Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine
No patent infringement found in exports of individual conjugate bulk substances and research-use finished products of pcv13 to russia company plans to export pcv13 vaccine components ’we aim for the global pcv market with our 21-valent and next-generation pneumococcal vaccines currently under development.’ seongnam, south korea , may 21, 2025 /prnewswire/ -- sk bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it the supreme court of korea has ruled in its favor in a patent infringement lawsuit filed by large global pharmaceutical giant pfizer over its 13-valent pneumococcal conjugate vaccine (pcv13). |
| 2025-05-19 20:00:00 |
Pfizer Enters Into Exclusive Licensing Agreement With 3sbio
New york--(business wire)--pfizer inc. (nyse: pfe) today announced it has entered into an exclusive global, ex-china, licensing agreement with 3sbio, inc. (01530.hk), a leading chinese biopharmaceutical company, for the development, manufacturing and commercialization of ssgj-707, a bispecific antibody targeting pd-1 and vegf, currently undergoing several clinical trials in china for non-small cell lung cancer, metastatic colorectal cancer, and gynecological tumors. ssgj-707 has shown initial e. |
| 2025-05-19 08:00:00 |
Astellas Presents New Data That Explores Potential Of Its Cancer Therapies At 2025 Asco Annual Meeting
16 abstracts, including two oral presentations, feature new clinical data from astellas’ oncology portfolio tokyo , may 19, 2025 /prnewswire/ -- astellas pharma inc. (tse: 4503, president and ceo: naoki okamura, ’astellas’) will present 16 abstracts featuring new data across its approved cancer therapies at the 2025 american society of clinical oncology (asco) annual meeting (may 30 - june 3). the research underscores astellas’ dedication as a pioneer in oncology and focus on clinical outcomes that matter to patients. |
| 2025-04-29 06:45:00 |
UGZpemVyIF JlcG9ydHMg U29saWQgRm lyc3QtcXVh cnRlciAyMD I1IFJlc3Vs dHMgQW5kIF JlYWZmaXJt cyAyMDI1IE d1aWRhbmNl
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgcm Vwb3J0ZWQg ZmluYW5jaW FsIHJlc3Vs dHMgZm9yIH RoZSBmaXJz dCBxdWFydG VyIG9mIDIw MjUgYW5kIH JlYWZmaXJt ZWQgaXRzID IwMjUgZmlu YW5jaWFsIG d1aWRhbmNl KDEpLiBleG VjdXRpdmUg Y29tbWVudG FyeSBkci4g YWxiZXJ0IG JvdXJsYSwg Y2hhaXJtYW 4gYW5kIGNl byBvZiBwZm l6ZXI6IOKA nHdlIGNvbn RpbnVlZCB0 byBleGVjdX RlIHdpdGgg Zm9jdXMgYW 5kIGRpc2Np cGxpbmUgYW dhaW5zdCBv dXIgc3RyYX RlZ2ljIHBy aW9yaXRpZX MsIGluY2x1 ZGluZyBzdH Jlbmd0aGVu aW5nIG91ci ByJmQgb3Jn YW5pemF0aW 9uIGFuZCBk cml2aW5nIG ltcHJvdmVk IHByb2R1Y3 Rpdml0eS4g d2l0aCB0aG UgdW5kZXJs eWluZyBzdH Jlbmd0aCBv ZiBvdXIgYn VzaW5lc3Ms IHdlIGJlbG lldmUgd2Ug Y2FuIGJlIG FnaWxlIGlu IG5hdmlnYX RpbmcgYW4g dW5jZXJ0YW luIGFuZCB2 b2wu
|
| 2025-04-26 13:30:00 |
UGZpemVy4o CZcyBTYXNh bmxpbWFiIE NvbWJpbmF0 aW9uIFNpZ2 5pZmljYW50 bHkgSW1wcm 92ZXMgRXZl bnQtZnJlZS BTdXJ2aXZh bCBJbiBCY2 ctbmHDj3Zl LCBIaWdoLX Jpc2sgTm9u LW11c2NsZS BJbnZhc2l2 ZSBCbGFkZG VyIENhbmNl cg==
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgdG 9kYXkgYW5u b3VuY2VkIH Jlc3VsdHMg ZnJvbSB0aG UgcGl2b3Rh bCBwaGFzZS AzIGNyZXN0 IHRyaWFsIG 9mIHNhc2Fu bGltYWIsIG FuIGludmVz dGlnYXRpb2 5hbCBhbnRp LXBkLTEgbW 9ub2Nsb25h bCBhbnRpYm 9keSAobWFi KSwgaW4gY2 9tYmluYXRp b24gd2l0aC BzdGFuZGFy ZCBvZiBjYX JlIChzb2Mp IGJhY2lsbH VzIGNhbG1l dHRlLWd1w4 lyaW4gKGJj ZykgYXMgaW 5kdWN0aW9u IHRoZXJhcH kgd2l0aCBv ciB3aXRob3 V0IG1haW50 ZW5hbmNlIG luIHBhdGll bnRzIHdpdG ggYmNnLW5h w492ZSwgaG lnaC1yaXNr IG5vbi1tdX NjbGUgaW52 YXNpdmUgYm xhZGRlciBj YW5jZXIgKG 5taWJjKS4g dGhlIHRyaW FsIG1ldCBp dHMgcHJpbW FyeSBlbmRw b2ludCBvZi BldmVudC1m cmVlIHN1cn ZpdmFsIChl ZnMpIGJ5IG ludmVzdGln YXRvciBhc3 Nlc3NtZW50 LCBkZW1vbn N0cmF0aW5n IGEgY2xpLg ==
|
| 2025-04-23 16:40:00 |
UGZpemVyIE RlY2xhcmVz IFNlY29uZC 1xdWFydGVy IDIwMjUgRG l2aWRlbmQ=
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgdG 9kYXkgYW5u b3VuY2VkIH RoYXQgaXRz IGJvYXJkIG 9mIGRpcmVj dG9ycyBkZW NsYXJlZCBh ICQwLjQzIH NlY29uZC1x dWFydGVyID IwMjUgZGl2 aWRlbmQgb2 4gdGhlIGNv bXBhbnnigJ lzIGNvbW1v biBzdG9jay wgcGF5YWJs ZSBqdW5lID EzLCAyMDI1 LCB0byBob2 xkZXJzIG9m IHRoZSBjb2 1tb24gc3Rv Y2sgb2Ygcm Vjb3JkIGF0 IHRoZSBjbG 9zZSBvZiBi dXNpbmVzcy BvbiBtYXkg OSwgMjAyNS 4gdGhlIHNl Y29uZC1xdW FydGVyIDIw MjUgY2FzaC BkaXZpZGVu ZCB3aWxsIG JlIHRoZSAz NDZ0aCBjb2 5zZWN1dGl2 ZSBxdWFydG VybHkgZGl2 aWRlbmQgcG FpZCBieSBw Zml6ZXIuIG Fib3V0IHBm aXplcjogYn JlYWt0aHJv dWdocyB0aG F0IGNoYW5n ZSBwYXRpZW 50c+KAmSBs aXZlcyBhdC BwZml6ZXIs IHdlIGFwcG x5IHNjaWVu Y2UgYW5kIG 91ciBnbG9i YWwgcmVzb3 VyY2VzIHRv IGJyaW5nIH Qu
|
| 2025-04-23 15:46:00 |
UGZpemVyIE FkdmFuY2Vz IEJvbGQgVm lzaW9uIEZv ciBGdXR1cm UgT2YgQ2Fu Y2VyIENhcm UgQXQgVGhl IEFzY28gMj AyNSBBbm51 YWwgTWVldG luZw==
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgd2 lsbCBzaG93 Y2FzZSBkYX RhIGFjcm9z cyBpdHMgcG 9ydGZvbGlv IG9mIHBvdG VudGlhbCBi cmVha3Rocm 91Z2ggY2Fu Y2VyIG1lZG ljaW5lcyBh dCB0aGUgMj AyNSBhbWVy aWNhbiBzb2 NpZXR5IG9m IGNsaW5pY2 FsIG9uY29s b2d5IChhc2 Nvwq4pIGFu bnVhbCBtZW V0aW5nLCB0 YWtpbmcgcG xhY2UgbWF5 IDMwIHRvIG p1bmUgMyBp biBjaGljYW dvLiBkYXRh IGZyb20gbW 9yZSB0aGFu IDYwIGNvbX Bhbnktc3Bv bnNvcmVkLC BpbnZlc3Rp Z2F0b3Itc3 BvbnNvcmVk LCBhbmQgY2 9sbGFib3Jh dGl2ZSByZX NlYXJjaCBh YnN0cmFjdH MsIGluY2x1 ZGluZyA5IG 9yYWwgcHJl c2VudGF0aW 9ucyBhbmQg NiByYXBpZC BvcmFsIHBy ZXNlbnRhdG lvbnMsIHdp bGwgYmUgcH Jlc2VudGVk IGFjcm9zcy BwZml6ZXLi gJlzIGtleS B0dW1vciBh cmVhcywgaW 5jbHVkaW5n IGJyZWFzdC wgZ2VuaXRv dXJpbmFyeS 4=
|
| 2025-04-16 16:15:00 |
QWNpcCBWb3 RlcyBUbyBF eHBhbmQgUm Vjb21tZW5k YXRpb24gRm 9yIFBmaXpl cuKAmXMgUn N2IFZhY2Np bmUgQWJyeX N2b8KuIFRv IEluY2x1ZG UgQWR1bHRz IEFnZWQgNT AgVG8gNTkg QXQgSW5jcm Vhc2VkIFJp c2sgT2YgRG lzZWFzZQ==
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgYW 5ub3VuY2Vk IHRvZGF5IH RoYXQgdGhl IHUucy4gY2 VudGVycyBm b3IgZGlzZW FzZSBjb250 cm9sIGFuZC BwcmV2ZW50 aW9u4oCZcy AoY2RjKSBh ZHZpc29yeS Bjb21taXR0 ZWUgb24gaW 1tdW5pemF0 aW9uIHByYW N0aWNlcyAo YWNpcCkgdm 90ZWQgdG8g ZXhwYW5kIG l0cyByZWNv bW1lbmRhdG lvbiBmb3Ig dGhlIHVzZS BvZiByZXNw aXJhdG9yeS BzeW5jeXRp YWwgdmlydX MgKHJzdikg dmFjY2luZX MgYXBwcm92 ZWQgZm9yIG FkdWx0cyA1 MC01OSB5ZW FycyBvZiBh Z2UgYXQgaW 5jcmVhc2Vk IHJpc2sgb2 YgcnN2LWFz c29jaWF0ZW QgbG93ZXIg cmVzcGlyYX RvcnkgdHJh Y3QgZGlzZW FzZSAobHJ0 ZCkuIHRoaX MgaW5jbHVk ZXMgYWJyeX N2b8KuIChy ZXNwaXJhdG 9yeSBzeW5j eXRpYWwgdm lydXMgdmFj Y2luZSksIH doaWNoIGlu IG9jdG9iZX IgMjAyNCwg dGhlIHUucy 4gZm9vZCBh bmQgZHJ1Zy 4=
|
| 2025-04-14 06:45:00 |
UGZpemVyIF Byb3ZpZGVz IFVwZGF0ZS BPbiBPcmFs IEdscC0xIF JlY2VwdG9y IEFnb25pc3 QgRGFudWds aXByb24=
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgdG 9kYXkgYW5u b3VuY2VkIH RoZSBkZWNp c2lvbiB0by BkaXNjb250 aW51ZSBkZX ZlbG9wbWVu dCBvZiBkYW 51Z2xpcHJv biAocGYtMD Y4ODI5NjEp LCBhbiBvcm FsIGdsdWNh Z29uLWxpa2 UgcGVwdGlk ZS0xIChnbH AtMSkgcmVj ZXB0b3IgYW dvbmlzdCwg d2hpY2ggd2 FzIGJlaW5n IGludmVzdG lnYXRlZCBm b3IgY2hyb2 5pYyB3ZWln aHQgbWFuYW dlbWVudC4g cGZpemVy4o CZcyBkb3Nl LW9wdGltaX phdGlvbiBz dHVkaWVzIG 9mIG9uY2Ut ZGFpbHkgZm 9ybXVsYXRp b25zIG9mIG RhbnVnbGlw cm9uIChuY3 QwNjU2NzMy NyBhbmQgbm N0MDY1Njg3 MzEpIG1ldC BrZXkgcGhh cm1hY29raW 5ldGljIG9i amVjdGl2ZX MgYW5kIGNv bmZpcm1lZC BhIGZvcm11 bGF0aW9uIG FuZCBkb3Nl IHdpdGggdG hlIHBvdGVu dGlhbCB0by BkZWxpdmVy IGEgY29tcG V0aXRpdmUg ZWZmaWNhY3 kgYW5kIHRv bGVyYWJpLg ==
|
| 2025-04-10 11:00:00 |
UGZpemVyIE ludml0ZXMg U2hhcmVob2 xkZXJzIFRv IEF0dGVuZC BWaXJ0dWFs IDIwMjUgQW 5udWFsIE1l ZXRpbmcgT2 YgU2hhcmVo b2xkZXJzIE 9uIEFwcmls IDI0
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgYW 5ub3VuY2Vk IHRvZGF5IH RoYXQgaXRz IHNoYXJlaG 9sZGVycyBh bmQgdGhlIG dlbmVyYWwg cHVibGljIG FyZSBpbnZp dGVkIHRvIG FjY2VzcyBp dHMgdmlydH VhbCAyMDI1 IGFubnVhbC BtZWV0aW5n IG9mIHNoYX JlaG9sZGVy cyBhdCA5Oj AwIGEubS4g ZWR0IG9uIH RodXJzZGF5 LCBhcHJpbC AyNCwgMjAy NS4gcGZpem VyIGhhcyBk ZXNpZ25lZC B0aGUgdmly dHVhbCBhbm 51YWwgbWVl dGluZyB0by BlbnN1cmUg dGhhdCBpdH Mgc2hhcmVo b2xkZXJzIH dobyBwYXJ0 aWNpcGF0ZS B3aWxsIGJl IGFmZm9yZG VkIGNvbXBh cmFibGUgcm lnaHRzIGFu ZCBvcHBvcn R1bml0aWVz IHRvIHBhcn RpY2lwYXRl IGFzIHRoZX kgd291bGQg YXQgYW4gaW 4tcGVyc29u IG1lZXRpbm cuIGJlZ2lu bmluZyB0b2 RheSwgc2hh cmVob2xkZX JzIGNhbiBm aW5kIGFkZG l0aW9uYWwg aW5mb3JtYX Rpb24gb24g YWNjZS4=
|
| 2025-04-04 13:35:00 |
RW50d2lzdG xlICYgQ2Fw cHVjY2kgTG xwIEZpbGVz IEEgU2VjdX JpdGllcyBD bGFzcyBBY3 Rpb24gQWdh aW5zdCBDZX JldmVsIFRo ZXJhcGV1dG ljcyBIb2xk aW5ncywgSW 5jLiwgQmFp biBDYXBpdG FsIEludmVz dG9ycywgTG xjIEFuZCBQ Zml6ZXIsIE luYy4=
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tZW50 d2lzdGxlIC YgY2FwcHVj Y2kgbGxwIC jigJxlbnR3 aXN0bGUgJi BjYXBwdWNj aeKAnSkgdG 9kYXkgYW5u b3VuY2VkIH RoYXQgaXRz IG9uZ29pbm cgaW52ZXN0 aWdhdGlvbi BoYXMgbGVk IHRvIHRoZS BmaWxpbmcg b2YgYSBjbG FzcyBhY3Rp b24gKHRoZS DigJxhY3Rp b27igJ0pIG FnYWluc3Qg Y2VyZXZlbC B0aGVyYXBl dXRpY3MgaG 9sZGluZ3Ms IGluYy4gKO KAnGNlcmV2 ZWzigJ0gb3 IgdGhlIOKA nGNvbXBhbn nigJ0pLCBi YWluIGNhcG l0YWwgaW52 ZXN0b3JzLC BsbGMgKOKA nGJhaW7igJ 0pIGFuZCBw Zml6ZXIsIG luYy4gKOKA nHBmaXplcu KAnSkgb24g YmVoYWxmIG 9mIGEgY2xh c3MgKHRoZS DigJxjbGFz c+KAnSkgY2 9uc2lzdGlu ZyBvZiBhbG wgcGVyc29u cyBvciBlbn RpdGllcyB0 aGF0OiAoYS kgc29sZCBv ciBvdGhlcn dpc2UgZGlz cG9zZWQgb2 YgdGhlIHB1 YmxpY2x5LX RyYWRlZCBj b21tb24gc3 RvY2sgb2Yg Y2VyZXZlbC BkdXJpbmcg dGhlIHBlcm lvLg==
|
| 2025-04-01 03:00:00 |
RXVyb3BlYW 4gQ29tbWlz c2lvbiBBcH Byb3ZlcyBQ Zml6ZXLigJ lzIFJzdiBW YWNjaW5lIE Ficnlzdm/C riBUbyBIZW xwIFByb3Rl Y3QgQWR1bH RzIEFnZWQg MTgtNTkgQW dhaW5zdCBS c3YgTG93ZX IgUmVzcGly YXRvcnkgVH JhY3QgRGlz ZWFzZQ==
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgYW 5ub3VuY2Vk IHRvZGF5IH RoYXQgdGhl IGV1cm9wZW FuIGNvbW1p c3Npb24gKG VjKSBoYXMg aXNzdWVkIG EgZGVjaXNp b24gYW1lbm RpbmcgdGhl IG1hcmtldG luZyBhdXRo b3JpemF0aW 9uIGZvciBh YnJ5c3Zvwq 4sIHRoZSBj b21wYW554o CZcyBiaXZh bGVudCByZX NwaXJhdG9y eSBzeW5jeX RpYWwgdmly dXMgKHJzdi kgcHJlZnVz aW9uIGYgKH JzdnByZWYp IHZhY2Npbm UsIHRvIGV4 dGVuZCB0aG UgaW5kaWNh dGlvbiB0by BpbmNsdWRl IHByZXZlbn Rpb24gb2Yg bG93ZXIgcm VzcGlyYXRv cnkgdHJhY3 QgZGlzZWFz ZSAobHJ0ZC kgY2F1c2Vk IGJ5IHJzdi BpbiBpbmRp dmlkdWFscy AxOCB0aHJv dWdoIDU5IH llYXJzIG9m IGFnZS4gdG hpcyBleHBh bmRzIHRoZS BwcmV2aW91 cyBhdXRob3 JpemF0aW9u IGZvciBpbm RpdmlkdWFs cyBhZ2VkID YwIGFuZCBv bGRlciwgYW 5kIGFicnlz dm8gbm93Lg ==
|
| 2025-03-18 10:00:00 |
UGZpemVyIE ludml0ZXMg UHVibGljIF RvIFZpZXcg QW5kIExpc3 RlbiBUbyBX ZWJjYXN0IE 9mIEFwcmls IDI5IENvbm ZlcmVuY2Ug Q2FsbCBXaX RoIEFuYWx5 c3Rz
TmV3IHlvcm stLShidXNp bmVzcyB3aX JlKS0tcGZp emVyIGluYy 4gKG55c2U6 IHBmZSkgaW 52aXRlcyBp bnZlc3Rvcn MgYW5kIHRo ZSBnZW5lcm FsIHB1Ymxp YyB0byB2aW V3IGFuZCBs aXN0ZW4gdG 8gYSB3ZWJj YXN0IG9mIG EgY29uZmVy ZW5jZSBjYW xsIHdpdGgg aW52ZXN0bW VudCBhbmFs eXN0cyBhdC AxMDowMCBh Lm0uIGVkdC BvbiB0dWVz ZGF5LCBhcH JpbCAyOSwg MjAyNS4gdG hlIHB1cnBv c2Ugb2YgdG hlIGNhbGwg aXMgdG8gcH JvdmlkZSBh biB1cGRhdG Ugb24gcGZp emVy4oCZcy ByZXN1bHRz LCBhcyByZW ZsZWN0ZWQg aW4gdGhlIG NvbXBhbnni gJlzIGZpcn N0IHF1YXJ0 ZXIgMjAyNS BwZXJmb3Jt YW5jZSByZX BvcnQsIHRv IGJlIGlzc3 VlZCB0aGF0 IG1vcm5pbm cuIHRvIHZp ZXcgYW5kIG xpc3RlbiB0 byB0aGUgd2 ViY2FzdCBh bmQgdmlldy B0aGUgcGVy Zm9ybWFuY2 UgcmVwb3J0 LCB2aXNpdC BvdXIgd2Vi IHNpdGUgYX Qgd3d3LnBm aXplci5jb2 0vaW52ZXN0 b3JzLiBpbm Yu
|
